Found: 7
Select item for more details and to access through your institution.
Phase 1 study in Japan of siltuximab, an anti-IL-6 monoclonal antibody, in relapsed/refractory multiple myeloma.
- Published in:
- International Journal of Hematology, 2015, v. 101, n. 3, p. 286, doi. 10.1007/s12185-015-1743-y
- By:
- Publication type:
- Article
Pharmacokinetics and safety of sirukumab following a single subcutaneous administration to healthy Japanese and Caucasian subjects.
- Published in:
- International Journal of Clinical Pharmacology & Therapeutics, 2013, v. 51, n. 3, p. 187, doi. 10.5414/CP201785
- By:
- Publication type:
- Article
Efficacy and safety of trelagliptin in Japanese patients with type 2 diabetes with severe renal impairment or end‐stage renal disease: Results from a randomized, phase 3 study.
- Published in:
- Journal of Diabetes Investigation, 2020, v. 11, n. 2, p. 373, doi. 10.1111/jdi.13126
- By:
- Publication type:
- Article
Comparative studies to determine the selective inhibitors for P-glycoprotein and cytochrome P 4503A4.
- Published in:
- AAPS Journal, 1999, v. 1, n. 4, p. 14, doi. 10.1208/ps010418
- By:
- Publication type:
- Article
Lack of Racial Differences in the Pharmacokinetics of Subcutaneous Golimumab in Healthy Japanese and Caucasian Male Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2010, v. 50, n. 7, p. 792, doi. 10.1177/0091270009355162
- By:
- Publication type:
- Article
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: a phase 2 multicenter study.
- Published in:
- Journal of Gastroenterology, 2021, v. 56, n. 2, p. 181, doi. 10.1007/s00535-020-01753-0
- By:
- Publication type:
- Article
751-P: First-in-Human, Single and Repeated Dose Study of SCO-267, a GPR40 Full Agonist, in Healthy Adults and Subjects with Glucose Intolerance.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-751-P
- By:
- Publication type:
- Article